193 results on '"G.F. Guazzoni"'
Search Results
2. The use of 29 MHz transrectal micro ultrasound to stratify the presence of prostate cancer in patients with an equivocal mpMRI: A single institutional analysis
3. The use OF 29 MHz transrectal micro ultrasound for the local staging of prostate cancer: A single institutional analysis
4. Clincally signicant prostate cancer diagnosis by micro-ultrasound guided prostate biopsies: A real-life single center experience
5. Diagnostic performance of micro-ultrasound prostate biopsies in patients undergoing mpMRI- fusion biopsie
6. Micro-ultrasound guided prostate biopsies for clinically significant prostate cancer diagnosis in a cohort of biopsy-naive patients with mpMRI
7. Diagnostic performance of micro-ultrasound in patients under active surveillance for low-risk prostate cancer
8. Micro-ultrasound guided and MRI-targeted prostate biopsies for clinically significant prostate cancer diagnosis in the initial biopsy setting a cohort of biopsy-naive patients
9. Diagnostic performance of micro-ultrasound in patients under active surveillance for low-risk prostate cancer
10. Oncological long-term safety and pathological outcome evaluation for patients under active surveillance for recurrent low-risk non-muscle invasive bladder cancer: Result from bladder cancer Italian active surveillance (BIAS) project
11. Laser lithotripter settings according to endoscopic view: How can we optimise the outcome? A simple way to optimise the treatment strategy
12. The utility of micro-ultrasound in patients under active surveillance for low-risk prostate cancer: A PRIAS study extension
13. Clinically significant prostate cancer diagnosis by micro-ultrasound guided prostate biopsies: A real-life single centre experience
14. Prospective comparison of PSMA PET/CT vs. mpMRI in patients with a high suspicion of prostate cancer and previously negative biopsy: Preliminary data from PROSPET-BX trial
15. Early oncological outcomes of a novel high-intensity focused ultrasound focal therapy program using a multi-imaging model for local and systemic staging of prostate cancer
16. A dedicated screening for early detection of prostate cancer in men with germline mutations in DNA-repair genes
17. Is testis sparing surgery safe in patients with incidental small testicular lesions referring to a fertility center? a retrospective analysis reporting factors correlated to malignancy and long-term oncological outcomes
18. The use OF 29 MHz transrectal micro ultrasound for the local staging of prostate cancer: A single institutional analysis
19. The use of 29 MHZ transrectal micro ultrasound to stratify the presence of prostate cancer in patients with an equivocal mpMRI: A single institutional analysis
20. Micro-ultrasound guided and MRI-targeted prostate biopsies for clinically significant prostate cancer diagnosis in the initial biopsy setting a cohort of biopsy-naive patients
21. Oncological long-term safety and pathological outcome evaluation for patients under active surveillance for recurrent low-risk non-muscle invasive bladder cancer: result from Bladder Cancer Italian Active Surveillance (BIAS) project
22. Head-to-head comparison between micro-ultrasound and MRI in the differentiation between muscle-invasive and non-muscle invasive bladder cancer: Results from the bladder microUS versus MRI cancer imaging staging study (BUS-MISS) protocol
23. Preliminary results of a European multicentre phase 1 study with Oncofid-P-B for the treatment of BCG unresponsive carcinoma in situ (CIS) of bladder at the end of 12 consecutive weeks intensive course and during ongoing monthly maintenance phase
24. Clinically significant prostate cancer diagnosis by micro-ultrasound guided prostate biopsies: A real-life single centre experience
25. Laser lithotripter settings according to endoscopic view: How can we optimise the outcome? A simple way to optimise the treatment strategy
26. Is robotic transperitoneal partial nephrectomy safe in the management of cystic renal cell masses? Outcomes of an ERUS multicenter study including 216 patients
27. Head-to-head comparison of high resolution micro-ultrasound and multiparametric magnetic resonance imaging for detecting extraprostatic extension in prostate cancer
28. Prostate biopsies by micro-ultrasound for clinically significant cancer detection: Results from a high-volume center
29. Micro-ultrasound guided prostate biopsies for clinically significant prostate cancer diagnosis in a cohort of biopsy-naive patients with MPMRI
30. Factors predicting active treatment free-survival: 10-year experience of active surveillance
31. A multi-centre evaluation of the role of Prostate Health Index (PHI) in regions with different prevalences of prostate cancer: A different reference range is needed for European and Asian
32. V10-01 ROBOT-ASSISTED PARTIAL NEPHRECTOMY: TECHNIQUES AND OUTCOMES FROM THE TRANSATLANTIC ROBOTIC NEPHRON-SPARING SURGERY (TRONES) STUDY GROUP
33. Multi-institutional retrospective validation of the the Simplified PADUA REnal (SPARE) nephromatry system for the prediction of potential morbidity of nephron-sparing surgery for renal masses
34. Factors predicting active treatment free-survival and initial experience with mpMRI as a selection tool in patient undergoing active surveillance: 10-year follow-up of SIUrO PRIAS-ITA working group
35. Real time High-Resolution Micro-Ultrasound guided biopsy: A new strategy to overcome systematic prostate biopsy
36. Update on the potential role of micro-ultrasound in the differentiation between muscle-invasive and non-muscle invasive bladder cancer
37. Diagnostic performance of micro-ultrasound prostate biopsies in patients undergoing mpMRI-fusion biopsies
38. Assessing the relationship between micro-ultrasound results and pathology at radical prostatectomy
39. Real-time micro-ultrasound guiding of systematic prostate biopsies: Preliminary results from a single-institutional experience
40. Diagnostic performance of micro-ultrasound in a contemporary cohort of patients in active surveillance for localized prostate cancer: A single-institutional experience
41. Profiling of the immune microenvironment in prostate cancer at single cell level
42. Mitomycin C triggers immunogenic cell death in bladder cancer cells
43. Prognostic role of neutrophil-to-lymphocyte ratio in patients with T1G3 non-muscle invasive bladder cancer
44. New conception for flexor vue deflecting endoscopic system use: Optimization of the stone free rate (SFR) After RIRS
45. Micro-ultrasound versus multiparametric MRI in the detection of prostate cancer: Results from a prospective single center trial
46. Assessing the diagnostic accuracy of micro-ultrasound for the detection of clinically significant prostate in the initial biopsy setting
47. Preliminary Results for The Bladder microUS vs. MRI cancer imaging Staging Study: The BUS-MISS
48. Micro-ultrasound target biopsies for the diagnosis of clinically significant prostate cancer: Results from a large single-center experience
49. Diagnostic performance of micro-ultrasound in patients under active surveillance for low-risk prostate cancer
50. Case report of a 75-year-old male with matrix stone disease: An alternative treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.